SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027509
Filing Date
2016-11-04
Accepted
2016-11-04 08:31:37
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20160930.htm 10-Q 1859901
2 EX-31.1 atra-ex311_6.htm EX-31.1 14883
3 EX-31.2 atra-ex312_7.htm EX-31.2 14862
4 EX-32.1 atra-ex321_8.htm EX-32.1 7731
  Complete submission text file 0001564590-16-027509.txt   5676523

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT atra-20160930.xml EX-101.INS 1230228
6 XBRL TAXONOMY EXTENSION SCHEMA atra-20160930.xsd EX-101.SCH 34388
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20160930_cal.xml EX-101.CAL 38102
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20160930_def.xml EX-101.DEF 93650
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20160930_lab.xml EX-101.LAB 294945
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20160930_pre.xml EX-101.PRE 206872
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 161973721
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences